Ption were detected. All analyses were performed with Stata version 10.1 (StataCorp, College Station, TX, USA). A two-sided P-value
E 2 cm ESR1-positive and ESR2-low, tumor size >2 cm ESR1-positive or ESR2-low or both, tumor size 2 cm ESR1-positive or ESR2-low or both, tumor size >2 cmaDisease-free survival Number 837 199 638 312 525 410 410 378 459 306 332 175 218 147 181 334 386 HR 95 CI P value 0.001 0.59 0.001 0.19 0.007 0.003 0.43 0.001 0.31 0.001 0.34 0.84 0.005 0.66 0.25 0.82 0.73 0.93 0.94 0.76 1.17 0.79 0.68 0.90 0
Ieuwerts et al.: Clinical significance of the nuclear receptor co-regulator DC-SCRIPT in breast cancer: an independent retrospective validation study. Breast Cancer Research 2010 12:R103.Submit your next manuscript to BioMed Central and take full advantage of:?Convenient online submission ?Thorough peer review ?No space constraints or color figure charges ?Immediate publication on acceptance ?Incl
Ieuwerts et al.: Clinical significance of the nuclear receptor co-regulator DC-SCRIPT in breast cancer: an independent retrospective validation study. Breast Cancer Research 2010 12:R103.Submit your next manuscript to BioMed Central and take full advantage of:?Convenient online submission ?Thorough peer review ?No space constraints or color figure charges ?Immediate publication on acceptance ?Incl
Istance, metabolic syndrome, and breast cancer recurrence: a cohort studySang Woo Oh1*, Cheol-Young Park2, Eun Sook Lee3, Yeong Sook Yoon4, Eon Sook Lee4, Sang Shin Park1,5, Yuil Kim1, Nak Jin Sung1, Young Ho Yun6, Keun Seok Lee7, Han Sung Kang7, Youngmee Kwon7 and Jungsil Ro7*AbstractIntroduction: Several in vitro studies have suggested the effects of adipokines and insulin resistance on breast c
Stic marker. The data that emerged from this study thus validate the hypothesis that DCSCRIPT is associated with good prognosis in early disease and support the idea that DC-SCRIPT acts as a tumor suppressor in breast cancer progression [7]. Because of the size of this cohort and the biological function of DC-SCRIPT as a nuclear receptor co-regulator, we were able to include additional subgroup an
Lpropane-1,3-diamine. Acknowledgements We especially thank the patients and surgeons, pathologists, and internists for their assistance in collecting tumor tissues and patients' clinical follow-up data. We thank Joan Bolt, Marion Meijer, Mieke Timmermans, Anita Trapman, and Wendy van der Smissen for their excellent technical support. This work was financially supported by VICI grant 918-66-615 (aw
Lpropane-1,3-diamine. Acknowledgements We especially thank the patients and surgeons, pathologists, and internists for their assistance in collecting tumor tissues and patients' clinical follow-up data. We thank Joan Bolt, Marion Meijer, Mieke Timmermans, Anita Trapman, and Wendy van der Smissen for their excellent technical support. This work was financially supported by VICI grant 918-66-615 (aw